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Isolation of Nontuberculous Mycobacteria (NTM) from Household
Water and Shower Aerosols in Patients with Pulmonary Disease
Caused by NTM
Rachel Thomson,a Carla Tolson,b Robyn Carter,b Chris Coulter,b Flavia Huygens,c Megan Hargreavesd
Gallipoli Medical Research Centre, Greenslopes Private Hospital, Brisbane, Queensland, Australiaa; Queensland Mycobacterium Reference Laboratory, Pathology
Queensland, RBWH Campus, Herston, Queensland, Australiab; Queensland University of Technology, Institute of Health and Biomedical Innovation, Kelvin Grove Campus,
Brisbane, Queensland, Australiac; Queensland University of Technology, Faculty of Science and Technology, Brisbane, Queensland, Australiad
It has been postulated that susceptible individuals may acquire infection with nontuberculous mycobacteria (NTM) fromwater
and aerosol exposure. This study examined household water and shower aerosols of patients with NTM pulmonary disease. The
mycobacteria isolated from clinical samples from 20 patients includedM. avium (5 patients),M. intracellulare (12 patients),M.
abscessus (7 patients),M. gordonae (1 patient),M. lentiflavum (1 patient),M. fortuitum (1 patient),M. peregrinum (1 patient),
M. chelonae (1 patient),M. triplex (1 patient), andM. kansasii (1 patient). One-liter water samples and swabs were collected
from all taps, and swimming pools or rainwater tanks. Shower aerosols were sampled using Andersen six-stage cascade impac-
tors. For a subgroup of patients, real-time PCR was performed and high-resolutionmelt profiles were compared to those of
ATCC control strains. Pathogenic mycobacteria were isolated from 19 homes. Species identified in the homematched that found
in the patient in seven (35%) cases:M. abscessus (3 cases),M. avium (1 case),M. gordonae (1 case),M. lentiflavum (1 case), and
M. kansasii (1 case). In an additional patient withM. abscessus infection, this species was isolated from potable water supplying
her home. NTM grown from aerosols includedM. abscessus (3 homes),M. gordonae (2 homes),M. kansasii (1 home),M. fortui-
tum complex (4 homes),M. mucogenicum (1 home), andM. wolinskyi (1 home). NTM causing human disease can be isolated
from household water and aerosols. The evidence appears strongest forM. avium,M. kansasii,M. lentiflavum, andM. absces-
sus. Despite a predominance of disease due toM. intracellulare, we found no evidence for acquisition of infection from house-
hold water for this species.
Nontuberculous mycobacteria (NTM) are ubiquitous organ-isms responsible for progressive pulmonary disease. Water is
a documented source of NTM infection in humans, although it is
not the only source. The incidence of pulmonary disease due to
environmental mycobacteria is increasing in many parts of the
world, including Australia (1). Reasons include increased aware-
ness of mycobacteria as pulmonary pathogens, improvements in
methods of detection and culture, and an aging population (as this
is often a disease of the elderly). An increase in exposure is also
possible as people are exposed to mycobacteria in water through
drinking, swimming, and bathing. Aerosols generated during
these activities can be inhaled, and water can be aspirated when
swallowed (2). Evidence linking human infection due to exposure
to Mycobacterium intracellulare and household dust (3), soil and
potting mix (4), and peat moss (5) also exists.
There is some evidence that susceptible individuals may ac-
quire infection from potable water in their own homes. To date
this evidence has been largely reported for Mycobacterium avium
(6–8). We recently documented NTM in the Brisbane, Australia,
potable water distribution system (9) and have shown that strains
of M. lentiflavum (10) and M. abscessus (11) are highly related or
identical to those found in patients with disease. Despite frequent
identification of Mycobacterium kansasii from water samples,
pathogenic strains were found infrequently (unpublished data).
M. intracellulare andM. aviumwere found infrequently in potable
water. It has been suggested that the low yield of M. intracellulare
from potable water samples is the result of insufficient sample
volume, difficulties with culture techniques, and the fact that per-
haps this species resides in the biofilm lining pipes and is released
only intermittently into water (12). Previous investigators have
documented the presence of mycobacteria in soil and house dusts
in Queensland (QLD) and have shown that 50% of environ-
mental strains were also found in human specimens, such as spu-
tum (3, 13, 14).
The aim of this study was to compare NTM found in household
water, biofilm, and aerosols generated by showering with the species
or strains causing infection in patients with known nontuberculous
mycobacterial pulmonary disease in Brisbane, Australia.
MATERIALS AND METHODS
Patients were recruited by the principal investigator (R.T.) through the
Respiratory Outpatient Department at The Prince Charles Hospital,
through clinics at the Queensland Tuberculosis Control Centre, and at
Greenslopes Private Hospital. Prevalent patients who had been resident in
the same dwelling for greater than 5 years prior to the diagnosis of NTM
disease were eligible for home sampling. Following signed informed con-
sent, the PI and assistant visited the homes to collect 1-liter samples of
water into sterile containers directly from kitchen, bathroom, and shower
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taps, rainwater tanks, and swimming pools (if applicable). Swabs were
taken from inside all taps and showerheads.
Aerosols from showers were sampled using Andersen six-stage cascade
impactors for viable air sampling (Grasby-Andersen, Smyrna, GA), which
provide validated particle size distribution data (15) and which have been
used previously to collect mycobacterial aerosols (16–18). The impactors
are calibrated at a flow rate of 28.3 liters/min, and samples were collected
onto petri dishes containing Mycobacteria 7H11 agar, supplemented with
OADC (oleic acid-albumin-dextrose-catalase) enrichment (100 ml/liter),
malachite green (25 mg/liter), and cycloheximide (500 mg/liter) (17). The
impactor was placed as close as practicable to the shower recess, and the
shower hot tap was run. Windows were left as the patient would normally
have them during showering, and exhaust fans were left off. The collection
time was 20 min. After collection, mycobacterial plates were sealed with
parafilm, packed in a plastic bag, and incubated at 30°C for 3 to 6 months.
Plates were read weekly, and purity plate subcultures were performed
using 7H11 agar.
Water samples were processed as previously described (9, 19). After
analysis of water sampling revealed an increased yield for rapidly growing
mycobacteria using liquid medium (MGIT tubes) (9), these were in-
cluded for the last 6 houses that were sampled. Swabs were placed in 2 ml
sterile distilled water (SDW) at time of collection, sealed, and transported
to the lab at room temperature. Each swab container was vortexed for 2
min and inoculated as per the water samples. Following initial inoculation
(M7H11 plates and MGIT tubes), the samples were decontaminated with
0.005% cetylpyridium chloride (CPC) for 30 min and further inoculated
for culture.
In a subgroup of seven patients, once samples were processed for cul-
ture, the remaining samples for each house were pooled according to
source (e.g., hot water, cold water, or swabs) and frozen for later PCR and
high-resolution melt curve (HRM) analysis.
HRM methodology. Frozen samples were thawed in a water bath at
65°C. One hundred milliliters of each sample was filtered through a 0.45-
m-pore-size (47-mm-diameter) membrane (Advantec, Tokyo, Japan).
Each filter was aseptically transferred into a separate sterile 50-ml tube
containing 10 ml sterile distilled water (SDW). The tubes were vortexed
for 8 to 10 min at 2,200 rpm, membranes were aseptically removed, and
the tubes were centrifuged at 4,750 rpm for 30 min at 4°C in a swinging-
bucket rotor.
The supernatant was discarded, and DNA was extracted using the
Power Water DNA isolation kit (Mo Bio Laboratories, Carlsbad, CA), as
follows. The pellet was transferred to the supplied Power Bead tube and
processed in a Mini-BeadBeater (BioSpec, Bartlesville, OK) for 5 min with
60 l kit-supplied C1 lysis buffer. The kit’s “Experienced user protocol”
was followed from the second step onwards, with the exception of a pri-
mary elution performed with 50 l DNase- and RNase-free deionized
water and a secondary elution performed with 100 l kit-supplied C6
elution buffer. The DNA extracts were stored at 80°C until use. All
samples and NTM ATCC controls (M. peregrinum ATCC 700686, M.
gordonae ATCC 14470, M. terrae ATCC 15755, M. scrofulaceum ATCC
19981, M. chelonae NCTC 946, M. fortuitum NCTC 10394, M. abscessus
ATCC 19977, M. avium 8867/GI/97, M. intracellulare ATCC 13950, M.
smegmatisATCC 19420,M. kansasiiTMC 1201, andM.malmoenseATCC
29571) were quantified using Nano Drop 1000 (Thermo Scientific, Aus-
tralia). The real-time PCRs were prepared to a volume of 20 l; their
constituents are shown in Table S1 in the supplemental material. Ampli-
fication was performed on the Rotor-gene Q real-time PCR instrument
(Qiagen Inc., Germantown, MD). Real-time PCR followed by HRM was
performed using the following conditions: step 1, hold at 95°C for 10 min;
step 2, cycling at 95°C for 10 s, 52°C for 15 s, and 72°C for 30 s and repeated
40 times; step 3, hold at 72°C for 5 min; and step 4, HRM, melt from 72 to
95°C rising by 0.05°C at each step. In all amplification reactions, negative
samples (whose constituents are listed in Table S2 in the supplemental
material) were used to avoid any possible contamination. Each assay in-
cluded 12 reference strains as positive controls to validate the character-
ization of the tested samples. All reactions were performed in duplicate.
Human samples were digested and decontaminated using 4% NaOH,
neutralized with phosphoric acid, and centrifuged at 3,000 g to concen-
trate the acid-fast bacilli (AFB). Smears were prepared from the sediment
and stained by the Ziehl-Neelsen (ZN) method. One Lowenstein-Jensen
slope (pyruvate) and a 7-ml MGIT tube were inoculated and incubated
at 35°C until growth was detected. ZN staining of colonies confirmed
AFB. Multiplex PCR (7) was performed to discriminate between M. tu-
berculosis, M. avium, M. intracellulare, M. abscessus, and other Mycobac-
terium spp. Isolates identified as other Mycobacterium spp. were further
determined to the species level using Hain Life Sciences GenoType Myco-
bacterium AS (additional species) kit (2004 to 2007 only) and/or 16S
rRNA sequencing in conjunction with phenotypic characteristics.
The clonality of clinical and water isolates was determined using a
method based on repetitive element palindromic PCR (Rep-PCR) (Diver-
silab system; bioMérieux, Melbourne, Australia). DNA was extracted
from clinical and water isolates using the Ultraclean microbial DNA iso-
lation kit (Mo Bio Laboratories). The PCR mixture was prepared using
AmpliTaq polymerase and PCR buffer (Applied Biosystems, Hamman-
ton, NJ) and Mycobacterium Diversilab primer mix according to the
manufacturer’s instructions. Separation and detection of Rep-PCR prod-
ucts were performed by microfluidic chips of the Diversilab System. Fin-
gerprints were analyzed with Diversilab software v.3.4.38 using the Pear-
son correlation coefficient and unweighted-pair group method with
arithmetic means to compare isolates and determine clonal relationships.
A similarity index of97% was used to define isolates that were indistin-
guishable, based on the manufacturer’s recommendations. Isolates that
shared 95% similarity were considered similar, and those with 90%
similarity were considered “different/unrelated.”
The protocol was approved by the Queensland University of Technol-
ogy Research Ethics Unit (approval no. 0900000085) and the Human
Research Ethics Committee of the Prince Charles Hospital (EC 2617).
RESULTS
The species of mycobacteria isolated from clinical samples from
20 patients included M. avium (5 patients), M. intracellulare (12
patients), M. abscessus (7 patients), M. gordonae (1 patient), M.
lentiflavum (1 patient), M. fortuitum (1 patient), M. peregrinum (1
patient), M. chelonae (1 patient), M. triplex (1 patient), and M.
kansasii (1 patient). Patient details are summarized in Table 1.
Twenty patients’ homes were sampled, and mycobacteria were
cultured from all but one home. (Full details are provided in Table
S1 in the supplemental material.) Species identified in the home
matched that found in the patient in seven (35%) cases: M. absces-
sus (3 cases), M. avium (1 case), M. gordonae (1 case), M. lentifla-
vum (1 case), and M. kansasii (1 case). In an additional patient
with M. abscessus infection, this species was isolated from potable
water in the reservoir zone supplying the home.
In those instances where the environmental isolate was cul-
tured (as opposed to direct detection using PCR), the strain type
matched that of the patient’s infecting strain in the patient withM.
kansasii infection (Fig. 1A). The clinical isolate of M. lentiflavum
was closely related to the M. lentiflavum isolate found in the pa-
tient’s house and the local water supply. (Fig. 1B) TheM. gordonae
isolate from patient’s sputum was unrelated to the isolate found in
the home water. Despite repeated attempts, the M. avium isolate
from the shower swab (patient P6) was unable to be regrown for
comparison with the patient’s clinical isolate. In one patient with
infection due to M. abscessus subsp. bolleti, a different strain type
of M. abscessus was grown from his shower water (Fig. 1C).
Results from Brisbane-wide sampling of water sites (distribu-
tion, reservoir, and trunk main samples) revealed a wide variety of
NTM Patient Home Sampling
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TABLE 1 Clinical details of patients whose homes were sampleda
Patient ID (gender;
age [yr])b
Other patient/sampling
environment characteristic(s) Radiology Microbiology and symptoms Clinical notes
P1 (F; 72) Gardener with pots BE S bronchial wash in 2007, M. abscessus; cough,
sputum, hemoptysis
Treated for 6 wk, clinically stable but
remained culture positive, died
from cancer of the pancreas in
2011
P2 (F; 69) Avid gardener BE Multiple S samples from 2004, progressive
radiology, wt loss, hemoptysis; M. intracellulare
in Sept and Dec 2004 (multiple), April 2006,
June 2007, and June 2008
Treated for 4 yr (ethambutol,
rifampin, clarithromycin,
clofazimine, and amikacin),
converted sputum in July 2009;
culture negative from 2010 to
June 2011
BE, small cavities New infiltrate, increased cough and hemoptysis; 2
positive sputa in June 2011 (1/3); in Sept 2011
(1/3), M. kansasii
Treated for 12 mo with ethambutol,
rifampin, and clarithromycin,
converted sputum, in remission
in 2013
P3 (M; 72) BE, nodules, large
cavities
Multiple SM. intracellulare, sputa from
April 2006, significant wt loss, cough
Partial clinical response to
treatment, but remains S C,
end-stage disease
P4 (F; 74) 400 orchids, exposure to
 peat moss
Nodules, BE, small
cavity
SM. intracellulare bronchial wash in Feb
2009; Pseudomonas aeruginosa, Aspergillus
fumigatus, Trichosporin sp.; cough, sputum,
hemoptysis
Treated with ethambutol, rifampin,
and clarithromycin, converted
sputum in Aug 2009; ongoing
hemoptysis; ceased treatment at
end of 2011
Relapse/reinfection in 2013, new infiltrate; 1/3
sputa S C/; bronchial wash S C in Jan
2013, M. intracellulare
Commenced retreatment in Feb
2013
P5 (F; 51) Rainwater tanks BE Multiple sputa positive in 2007 for M. avium;
previous S. aureus, new radiology, symptoms
Treated for 18 mo, converted
sputum, still in remission
P6 (F; 72) Large fernery, rainwater tanks BE Cough, sputum, respiratory failure, cachexia,
progressive radiology; M. avium in 2007; M.
intracellulare in 2006 and 2008
Died from disease despite treatment
in 2011
P7 (F; 85) Rainwater tanks Nodules, BE Cough, sputum, wt loss, sweats; bronchial wash in
April 2008, Mycobacterium species; OLB in Nov
2008, M. lentiflavum
Treated for 2 yr with ethambutol,
rifampin, and clarithromycin,
remains in remission; P.
aeruginosa
P8 (F; 63) Rainwater tanks BE Recurrent LRTIs, persistent cough; bronchial
wash in Nov 2007; in July 2008 and May 2010,
M. intracellulare
Treated for 2 yr with ethambutol,
rifampin, and clarithromycin, in
remission
P9 (F; 63) Gardener BE, nodules Hemoptysis; bronchial wash in Jan 2006, in Aug
2007, M. intracellulare
Treated for 18 mo, RML lobectomy
in 2011; relapse/reinfection in
2013
P10 (M; 81) BE, nodules Cough, sputum, SOB; bronchial wash in Oct 2007,
M. intracellulare; sputum, M. abscessus, in Jan
2008, Apr 2008, and Sept 2008 and in 2012
Treated for 6 wk with i.v. amikacin,
cefoxitin, and clarithromycin in
2010 and for 2 wk in 2012
P11 (F; 75) Didn’t use shower, gardener,
very dusty house
BE Recurrent infections in RML, S. aureus; M.
intracellulare isolated most frequently; M.
intracellulare in March 2006; slow grower in
April 2008; M. abscessus in June 2008; M.
intracellulare in July 2008; M. peregrinum in
July 2008; M. gordonae in Aug 2008; M.
intracellulare in Sept to Dec 2008 (multiple);
M. peregrinum in Dec 2008; M. intracellulare in
Feb 2009 (multiple); M. peregrinum in March
2009; M. fortuitum in March 2009; M.
fortuitum in May 2009; M. intracellulare in Oct
2009; M. fortuitum complex in Dec 2009; M.
intracellulare in Jan 2010
Treated for 24 mo with ethambutol,
rifampin, clarithromycin, and
ciprofloxacin, showed some
symptomatic improvement, but
didn’t convert sputum; currently
stable off treatment with chronic
cough, sputum, and lethargy but
reluctant for retreatment
P12 (M; 69) Cactus house (300 plants) BE, nodules, cavities M. intracellulare in 2003–2004; M. triplex in 2006;
M. avium and M. intracellulare in 2007; M.
intracellulare in 2008; Nocardia farcinica in
2009; M. intracellulare in 2009
Treated over 3–4 yr, drug
intolerances, peripheral
neuropathy; eventually converted
sputum; remains in remission
P13 (F; 60) BE, nodules M. intracellulare repeatedly from 2000–2007; M.
avium after 15-mo remission in March 2005;
RGM single isolates while on treatment for
SGM; M. chelonae in May 2005; M. abscessus in
Jan 2007
RML lobectomy following 4 yr of
treatment, drug side effects, and
short relapse time; now deceased
secondary to NTM disease
P14 (M; 85) Cavities M. intracellulare in Dec 2006, March 2007, and
April 2007
Treated for 18 mo with ethambutol,
rifampin, and clarithromycin,
converted sputum
P15 (M; 25) BE, nodules,
bronchiolitis
Post-pertussis bronchiolitis with secondary
infection, M. abscessus subsp. bolletii in July-
Sept 2011
Treated for 6 mo with amikacin,
cefoxitin, clarithromycin, and
clofazimine
P16 (F; 60) RML BE M. avium bronchial wash in 2007 Treated for 6 mo, intolerant of
medication; stable and culture
negative off treatment
P17 (F; 77) BE M. intracellulare in 2000; M. abscessus (multiple),
including Sept 2008, Oct 2009, and Feb 2011
M. intracellulare treated in 2000; in
2007, multiple courses of
treatment for M. abscessus with
partial response, limited by drug
toxicity; respiratory failure
secondary to disease, death
(Continued on following page)
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NTM (18). Some of these NTM (especially M. kansasii, M. gor-
donae, M. fortuitum, and M. mucogenicum), which were cultured
from 16 homes, matched the species isolated from sampling sites
near the patients’ homes. In two instances (patients P10 and P19),
M. abscessus was cultured from water close to the homes of these
patients with M. abscessus disease and the strains were closely re-
lated to those found in their clinical samples (Fig. 1D). Similarly in
the patient with M. lentiflavum infection, the municipal water
isolates were similar to the home and clinical isolates (Fig. 1B). Of
four other patients for which the infecting NTM species was iso-
lated from their home samples (patients P1, P2, P9, and P11), the
species was also isolated from local water sampling sites. (A full
table that includes isolates cultured from reservoir zones supply-
ing each patient’s house and the distance from the house to the
sampling point is given in Table S2 in the supplemental material.)
Aerosols were collected in 18 homes. The culture plates were
overgrown in 6 patients, negative at 6 months in 3, but grew NTM
in the remaining 9 (50%). The species identified included M. ab-
scessus (3 homes, including one patient with disease due to M.
abscessus), M. gordonae (2 patients), M. kansasii (1 patient), M.
fortuitum complex (4 patients), M. mucogenicum (1 patient), and
M. wolinskyi (1 patient).
DISCUSSION
In this study, we have demonstrated that NTM present in potable
water distribution systems can also be found in the houses of pa-
tients with NTM disease and can be grown from aerosols gener-
ated by showering. Matching human and environmental strains
were found for M. abscessus, M. lentiflavum, and M. kansasii.
Other investigators have explored the possibility that patients with
NTM disease (predominantly M. avium and M. intracellulare)
may have acquired their infection from water sources in the home.
A Japanese group (8) looked at the isolation of NTM from the
homes of 49 patients with M. avium complex (MAC) pulmonary
disease and 43 healthy volunteers without MAC disease. From
each home, three 200-ml water samples (kitchen tap, showerhead,
and used bathtub water) were collected. In addition, scale on the
surface of showerheads, slime from 3 drains, and dust from air
conditioners was sampled. Eleven samples contained MAC: 10
were from 9/49 patients’ residences, and 1 was from the 43 volun-
teers’ residences. Eight isolates were M. avium, and 3 were
M. intracellulare—a similar ratio to the species causing pulmonary
disease in the Japanese population. The isolates from the patients’
bathrooms were compared with those from their sputum samples,
and 2 had identical pulsed-field gel electrophoresis (PFGE) pat-
terns and serotypes. For 4 patients the isolates were the same spe-
cies but had different restriction fragment length polymorphism
(RFLP) or PFGE profiles. Interestingly only bathroom samples
were positive: MAC was not isolated from kitchen tap water, yet
the same system was supplying water to the whole house. The
authors postulate that favorable temperature and humidity allow
MAC to preferentially colonize the bathroom. However, the fre-
quency of use of kitchen taps may allow more flushing out of
mycobacteria from pipes, and the possibility that expectorating
patients may have contaminated bathroom drains should not be
discounted. In the single patient who had M. intracellulare infec-
tion, where the pathogen was grown only from a drain site, this
may certainly have been the case.
Falkinham (7) reported the results of home water sampling
from 31 patients (with 37 homes) in the United States and Canada
with NTM disease. Patients included in the study had infection
with M. avium (9 patients), M. intracellulare (6 patients), MAC
(11 patients), M. abscessus (4 patients), and M. xenopi (1 patient).
Forty-nine percent of households sampled grew NTM, including
M. avium (10 homes),M. intracellulare (10 homes),M.malmoense
(5 homes), M. szulgai (3 homes), M. gordonae (6 homes), M. che-
lonae (2 homes), M. scrofulaceum (1 home), M. triviale (1 home),
and M. terrae (1 home). In 17/37 (46%) homes, a species was
isolated that matched the patient’s infecting species, and in seven
of these the strains had matching Rep-PCR patterns. Details of
these matching species are not reported in the paper—although
two of the matching strains illustrated were M. avium. In contrast
to our findings, there were a greater yield of M. intracellulare and
an absence of M. abscessus in home samples.
Aerosol sampling for NTM has been performed previously to
investigate hot tubs and indoor pools as a source of NTM (20). It
has also been used to document NTM in air samples collected
TABLE 1 (Continued)
Patient ID (gender;
age [yr])b
Other patient/sampling
environment characteristic(s) Radiology Microbiology and symptoms Clinical notes
P18 (F; 53) Large cavities,
nodules, BE
M. abscessus sputum in Oct 2010, bronchial wash
in Dec 2010 (with S. aureus) and Dec 2012 and
multiple in between
Heavy smoker of cigarettes,
marijuana, large cavities; treated
with i.v. therapy, response when
abstinent from cigarettes; died
from cancer of the lung and
progressive cavitary disease
P19 (F; 80) BE M. abscessus in March and April 2011 Treated for 2 wk with amikacin and
cefoxitin and 6 wk with
clarithromycin and clofazimine;
in remission
P20 (F; 65) Nodular BE M. intracellulare in 2007, bronchial wash,
granulomata on TBB
Progressive radiology and
symptoms; treated with
ethambutol, rifabutin, and
clarithromycin in 2010; rash and
hepatitis; treated with
azithromycin, ethambutol,
clofazimine, and amikacin, in
remission
a Abbreviations: F, female; M, male; BE, bronchiectasis; S, smear; C, culture; LRTIs, lower respiratory tract infections; SOB, shortness of breath; RGM, rapidly growing
mycobacteria; SGM, slowly growing mycobacteria; OLB, open lung biopsy; TBB, transbronchial lung biopsy. For smear and culture results, and indicate positive and negative
to the general degree shown (where is positive and is highly positive).
b Age calculated from date of first isolate.
NTM Patient Home Sampling
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during the remediation of an old building (17) and from a peat
moss processing plant (5). De Groote (4) analyzed aerosols gen-
erated by the pouring of commercial potting mix using the An-
dersen impactor. The isolates shown to be acid fast were presump-
tively called mycobacteria but not identified further.
Ours is the first study to examine the household shower aero-
sols as a potential source of NTM. We have demonstrated that a
variety of species can be aerosolized and cultured from droplets of
a respirable size. The most significant of these is M. abscessus,
which was found in aerosols of patients with disease. We did not
demonstrate the aerosolization of M. intracellulare, which was the
main pathogen associated with disease in the patients studied.
The yield of M. intracellulare from both Brisbane water (9) and
home samples was interesting. Falkinham (12) has suggested that
in previous water studies the low yield was due to an insufficient
number of specimens or the lack of biofilm specimens. In our
study, however, a large number of samples and relatively larger
volume of water samples were collected, and biofilm samples were
collected from every tap. There may be issues with detection, al-
though the use of direct detection using HRM didn’t increase the
yield for M. intracellulare (yet did find other NTM). Faezel (21)
reported extensive sampling of the biofilm of showerheads in the
United States, and while M. avium was found, no M. intracellulare
was reported. In both of the other home sampling papers, there
was no evidence to support the proposal that patients with M.
intracellulare disease had acquired infection from water sources.
These findings in combination with the earlier studies done by
Dawson (3, 13, 14) on house dust and soil suggest that Queensland
patients at least may be more likely to acquire M. intracellulare
from soil or dust than from water.
FIG 1 Rep-PCR dendrograms of (A) M. kansasii isolated from patient sputum (patient P2) and samples from the patient’s home, (B) M. lentiflavum isolated
from patient P7, her home water, and surrounding water distribution sites, (C) M. abscessus subsp. bolletii from one patient and M. abscessus subsp. abscessus
grown from shower water, and (D) M. abscessus isolated from 2 patients and from the water supply close to their homes.
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More recently Fujita (22) conducted a large survey of soils
from 100 patients with MAC infection. In those with high soil
exposure (2 h/week), 6/16 patients had matching soil and clin-
ical isolates using variable-number tandem repeat (VNTR) pro-
files (5 M. avium and 1 M. intracellulare). This compared with
none of the 19 patients with low or no soil exposure, again sug-
gesting that residential soils may also be a source of exposure for
patients with MAC disease.
A major limitation of home water and soil sampling studies
relates to the long lag time between exposure and infection that
can occur with NTM disease. Quite often a patient has had symp-
toms for many years prior to diagnosis, and hence, establishing the
environment in which they were exposed is often very difficult.
Patients are also potentially exposed to NTM outside their home.
It is also worth considering the close relationship between soil and
water in the environment, in activities such as gardening and in
the situation of soil entering water distribution networks through
cracks in pipes and rainwater tanks via household roofs.
In summary, we have shown that pathogenic NTM can be iso-
lated from water, biofilm, and aerosols in the households of pa-
tients with NTM disease. The presence of matching clinical and
patient isolates was demonstrated. From our work and other lit-
erature, the evidence supporting water as a source of infection
would appear greatest for M. avium, M. abscessus, M. lentiflavum,
and M. kansasii. However, there appears little evidence for M.
intracellulare, and soil exposure may be more relevant.
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